NCT01090570View on ClinicalTrials.gov

Safety, Pharmacokinetic (PK), Pharmcodynamic (PD), and Drug-Drug Interaction of PLX3397 in Patients With Rheumatoid Arthritis Who Are Receiving Methotrexate

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

May 31, 2010

Primary Completion Date

December 31, 2010

Conditions
Rheumatoid Arthritis
Interventions
DRUG

PLX3397

Once-daily oral capsules

Trial Locations (5)

Unknown

Tuscaloosa

Little Rock

San Francisco

Altoona

Dallas

Sponsors

Lead Sponsor

Plexxikon
All Listed Sponsors
lead

Plexxikon

INDUSTRY

NCT01090570 - Safety, Pharmacokinetic (PK), Pharmcodynamic (PD), and Drug-Drug Interaction of PLX3397 in Patients With Rheumatoid Arthritis Who Are Receiving Methotrexate | Biotech Hunter | Biotech Hunter